TrialGynecologic oncology2015

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.

James S Ferriss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.